August 7th 2021, 4:00pm
A breast cancer survivor lists 5 steps that she will take to get her health back on track.
June 7th 2021, 1:00pm
The long-term follow-up data, according to one of the study’s authors from the Sarah Cannon Cancer Institute, demonstrate “a new benchmark for the standard of care” in the treatment of patients with unresectable stage 3 non-small cell lung cancer.
June 7th 2021, 12:00pm
Treatment with aumolertinib was associated with prolonged survival in patients with advanced non-small cell lung cancer.
June 6th 2021, 8:00pm
After long-term follow-up, the CAR-T cell therapy still boosted survival outcomes in patients with relapsed/refractory multiple myeloma, regardless of the number of prior lines of therapy received.
June 6th 2021, 7:00pm
Previously treated patients with non-small cell lung cancer tended to have better responses with Retevmo than they did with prior treatments.
June 6th 2021, 5:00pm
Treatment with a novel combination therapy was associated with increased efficacy among patients with aggressive relapsed or refractory B-cell non-Hodgkin lymphoma and was also well tolerated.
June 5th 2021, 3:00pm
Adding Opdivo to treatment with Yervoy or chemotherapy improved survival, compared with chemotherapy alone in patients with unresectable and advanced esophageal cancer.
June 5th 2021, 1:00pm
The addition of a novel drug to the chemotherapies gemcitabine and cisplatin significantly improved a survival outcome in patients with a rare form of head and neck cancer, compared with chemotherapy alone.
April 30th 2021, 3:22pm
View the entire 2021 Extraordinary Healer® Award for Oncology Nursing virtual presentation here!